Catheter-related bloodstream infections, part I: Pathogenesis, diagnosis, and management

Cancer Control

Volumn 9, Issue 6, 2002, Pages 513-523

  Ferretti, Gianluigi ^a   Mandalà, Mario ^b   Di Cosimo, Serena ^c   Moro, Cecilia ^d   Curigliano, Giuseppe ^e   Barni, Sandro ^b  

^a SANTA MARIA GORETTI HOSPITAL   (Italy)

^b TREVIGLIO HOSPITAL   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d IRCCS   (Italy)

^e EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTERY CATHETER; BACTEREMIA; BACTERIAL ENDOCARDITIS; BACTERIUM CULTURE; BIOFILM; BLOOD CULTURE; CANDIDA ALBICANS; CENTRAL VENOUS CATHETER; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FUNGEMIA; GRAM STAINING; HUMAN; INTRAVENOUS CATHETER; PATHOGENESIS; REVIEW; RISK FACTOR; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOSIS; VEIN PUNCTURE;

EID: 0036863754     PISSN: 10732748     EISSN: None     Source Type: Journal    
DOI: 10.1177/107327480200900610     Document Type: Review

References (88)

1. Gross PA, Barrett TL, Dellinger PE, et al. Purpose of quality standards for infectious diseases. Infectious Diseases Society of America. Clin Infect Dis. 1994;18:421.
2. Maki DG, Mermel LA. Infections due to infusion therapy. In: Bennett JV, Brachman PS, eds. Hospital Infections. Philadelphia, Pa: Lippincott-Raven; 1998.
3. Pearson ML. Guideline for prevention of intravascular device-related infections. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1996;17:438-473.
4. Jarvis WR, Edwards JE, Culver DH, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. Am J Med. 1991;91(suppl 3B):185S-191S.
5. Mayhall CG. Diagnosis and management of infections of implantable devices used for prolonged venous access. Curr Clin Top Infect Dis. 1992;12:83-110.
6. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients: Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271: 1598-1601.
7. Heiselman D. Nosocomial blood-stream infections in the critically ill. JAMA. 1994;272:1819-1820.
8. Edgeworth JD, Treacher DF, Eykyn SJ. A 25-year study of nosocomial bacteremia in an adult intensive care unit. Crit Care Med. 1999;27:1421-1428.
9. Maki DG, Stolz SM, Wheeler S, et al. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127: 257-266.
10. Mermel LA, McCormick RD, Springman SR, et al. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: A prospective study utilizing molecular subtyping. Am J Med. 1991;91:197S-205S.
11. Raad I, Costerton W, Sabharwal U, et al. Ultrastructural analysis of indwelling vascular catheters: A quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168:400-407.
12. Lopes JD, dos Reis M, Brentani RR. Presence of laminin receptors in Staphylococcus aureus. Science. 1985;229:275-277.
13. Herrmann M, Suchard SJ, Boxer LA, et al. Thrombospondin binds to Staphylococcus aureus and promotes staphylococcal adherence to surfaces. Infect Immun. 1991;59:279-288.
14. Herrmann M,Vaudaux PE, Pittet D, et al. Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material. J Infect Dis. 1988;158:693-701.
15. Vaudaux P, Pittet D, Haeberli A, et al. Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis. 1993;167:633-641.
16. Nilsson M, Frykberg L, Flock JI, et al. A fibrinogen-binding protein of Staphylococcus epidermidis. Infect Immun. 1998; 66:2666-2673.
17. Hanna HA, Raad I. Blood products: A significant risk factor for long-term catheter-related bloodstream infections in cancer patients. Infect Control Hosp Epidemiol. 2001;22:165-166.
18. Mermel LA. Bacteriology, safety and prevention of infection associated with continuous intravenous infusions. Blood Coagul Fibrinolysis. 1996;7(suppl 1):S45-S51.
19. Kiehn TE, Armstrong D. Changes in the spectrum of organisms causing bacteremia and fungemia in immunocompromised patients due to venous access devices. Eur J Clin Microbiol Infect Dis. 1990;9:869-872.
20. Kristinsson KG. Diagnosis of catheter-related infections. In: Seifert H, Jansen B, Farr BM, eds. Catheter-Related Infections. NewYork, NY: M Dekker; 1997.
21. Cooper GL, Hopkins CC. Rapid diagnosis of intravascular catheter-associated infection by direct gram staining of catheter segments. N Engl J Med. 1985;312:1142-1147.
22. Kite P, Dobbins BM, Wilcox MH, et al. Rapid diagnosis of central-venous-catheter-related bloodstream infection without catheter removal. Lancet. 1999;354:1504-1507.
23. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med. 1977;296:1305-1309.
24. Cleri DJ, Corrado ML, Seligman SJ. Quantitative culture of intravenous catheters and other intravascular inserts. J Infect Dis. 1980;141:781-786.
25. Brun-Buisson C,Abrouk F, Legrand P, et al. Diagnosis of central venous catheter-related sepsis. Critical level of quantitative tip cultures. Arch Intern Med. 1987;147: 873-877.
26. Schmitt SK, Knapp C, Hall GS, et al. Impact of chlorhexidine-silver sulfadiazine-impregnated central venous catheters on in vitro quantitation of catheter-associated bacteria. J Clin Microbiol. 1996;34:508-511.
27. Bouza E, Burillo A, Munoz P. Catheter-related infections: Diagnosis and intravascular treatment. Clin Microbiol Infect. 2002;8:265-274.
28. Sherertz RJ, Raad II, Belani A, et al. Three-year experience with sonicated vascular catheter cultures in a clinical microbiology laboratory. J Clin Microbiol. 1990;28: 76-82.
29. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med. 1998;158:81-87.
30. Widmer AF, Nettleman M, Flint K, et al. The clinical impact of culturing central venous catheters. A prospective study. Arch Intern Med. 1992;152:1299-1302.
31. DesJardin JA, Falagas ME, Ruthazer R, et al. Clinical utility of blood cultures drawn from indwelling central venous catheters in hospitalized patients with cancer. Ann Intern Med. 1999;131:641-647.
32. Fan ST, Teoh-Chan CH, Lau KE. Evaluation of central venous catheter sepsis by differential quantitative blood culture. Eur J Clin Microbiol Infect Dis. 1989;8:142-144.
33. Capdevila JA, Planes AM, Polomar M, et al. Value of differential quantitative blood cultures in the diagnosis of catheter-related sepsis. Eur J Clin Microbiol Infect Dis. 1992;11:403-407.
34. Kite P, Dobbins BM, Wilcox MH, et al. Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter-related sepsis. J Clin Pathol. 1997;50:278-282.
35. Blot F, Schmidt E, Nitenberg G, et al. Earlier positivity of central-venous-versus peripheral-blood cultures is highly predictive of catheter-related sepsis. J Clin Microbiol. 1998;36:105-109.
36. Blot F, Nitenberg G, Chachaty E, et al. Diagnosis of catheter-related bacteraemia: A prospective comparison of the time to positivity of hub-blood versus peripheral-blood cultures. Lancet. 1999;354:1071-1077.
37. Whitman ED, Boatman AM. Comparison of diagnostic specimens and methods to evaluate infected venous access ports. Am J Surg. 1995;170:665-670.
38. Douard MC, Arlet G, Longuet P, et al. Diagnosis of venous access port related infections. Clin Infect Dis. 1999;29:1197- 1202.
39. Fidalgo S,Vazquez F, Mendoza MC, et al. Bacteremia due to Staphylococcus epidermidis: Microbiologic, epidemiologic, clinical, and prognostic features. Rev Infect Dis. 1990;12:520-528.
40. Pollack PF, Kadden M, Byrne WJ, et al. 100 Patient years' experience with the Broviac silastic catheter for central venous nutrition. JPEN J Parenter Enteral Nutr. 1981;5:32-36.
41. Herrmann M, Peters G. Catheter-associated infections caused by coagulase-negative staphylococci: Clinical and biological aspects. In: Seifert H, Jansen B, Farr BM, eds. Catheter-Related Infections. New York, NY: M Dekker; 1997.
42. Raad I, Davis S, Khan A, et al. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococci bacteremia. Infect Control Hosp Epidemiol. 1992;13:215-221.
43. Raad II, Sabbagh MF. Optimal duration of therapy for catheter-related Staphylococcus aureus bacteremia: A study of 55 cases and review. Clin Infect Dis. 1992;14: 75-82.
44. Raad I, Narro J, Khan A, et al. Serious complications of vascular catheter-related Staphylococcus aureus bacteremia in cancer patients. Eur J Clin Microbiol Infect Dis. 1992;11:675-682.
45. Malanoski GJ, Samore MH, Pefanis A, et al. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med. 1995;155:1161-1166.
46. Greene JN. Infections related to vascular access devices. Cancer Control. 1996;3:456-464.
47. Rosen AB, Fowler VG Jr, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med. 1999;130:810-820.
48. Krywda E, Gotoff R, Andris D, et al. Antibiotic lock treatment (ALT): Impact on catheter salvage and cost savings. In: Program and Abstracts of the 35th Interscience Conference of Antimicrobial Agents and Chemotherapy. San Francisco, Calif; 1995:AJ4. Abstract.
49. Guedon C, Nouvellon M, Lalaude O, et al. Efficacy of antibiotic-lock technique with teicoplanin in staphylococcus epidermidis catheter-related sepsis during long-term parenteral nutrition. JPEN J Parenter Enteral Nutr. 2002;26:109-113.
50. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Clinical features and management. Ann Surg. 1985;202:653-658.
51. Raviglione MC, Battan R, Pablos-Mendez A, et al. Infections associated with Hickman catheters in patients with acquired immunodeficiency syndrome. Am J Med. 1989;86(pt 2):780-786.
52. Gold HS, Karchmer AW. Catheter-associated Staphylococcus aureus bacteremia. Hosp Pract (Off Ed). 1996;31:133-137, 142-144, 150.
53. Lecciones JA, Lee JW, Navarro EE, et al. Vascular catheter-associated fungemia in patients with cancer: Analysis of 155 episodes. Clin Infect Dis. 1992;14:875-883.
54. Ashby MJ, Neale JE, Knott SJ, et al. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J Antimicrob Chemother. 1994;33:443-452.
55. Strinden WD, Helgerson RB, Maki DG. Candida septic thrombosis of the great central veins associated with central catheters. Ann Surg. 1985;202:653-658.
56. Dugdale DC, Ramsey PG. Staphylococcus aureus bacteremia in patients with Hickman catheters. Am J Med. 1990;89: 137-141.
57. Gill MV, Klein NC, Cunha BA. Unusual organisms causing intravenous line infections in compromised hosts. I. Bacterial and algal infections. Infect Dis Clin Pract. 1996; 5:244-255.
58. Raad I, Bompart F, Hachem R. Prospective, randomized dose-ranging open phase II pilot study of quinupristin/dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia. Eur J Clin Microbiol Infect Dis. 1999;18:199-202.
59. Garcia R, Raad I. In vitro study of the potential role of quinupristin/dalfopristin in the treatment of catheter-related staphylococcal infections. Eur J Clin Microbiol Infect Dis. 1996;15:933-936.
60. Moellering RC Jr. A novel antimicrobial agent joins the battle against resistant bacteria. Ann Intern Med. 1999;130:155-157.
61. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs. 2001;24:180-205.
62. Steinberg JP, Clark CC, Hackman BO. Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: Impact of intravascular devices and methicillin resistance. Clin Infect Dis. 1996;23:255-259.
63. Zeylemaker MM, Jaspers CA, van Kraaij MG, et al. Long-term infectious complications and their relation to treatment duration in catheter-related Staphylococcus aureus bacteremia. Eur J Clin Microbiol Infect Dis. 2001;20:380-384.
64. Meunier F. Management of candidemia. N Engl J Med. 1994;331:1371-1372.
65. Anaissie EJ, Vartivarian SE, Abi-Said D, et al. Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: A matched cohort study. Am J Med. 1996;101:170-176.
66. Pfaller MA, Barry AL. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method. Mycopathologia. 1995;130:3-9.
67. Berrouane YF, Hollis RJ, Pfaller MA. Strain variation among and antifungal susceptibilities of isolates of Candida krusei. J Clin Microbiol. 1996;34:1856-1858.
68. Rex JH, Walsh TJ, Sobel JD, et al. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America. Clin Infect Dis. 2000;30:662-678.
69. Rex JH, Bennett JE, Sugar AM, et al. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. N Engl J Med. 1994;331: 1325-1330.
70. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. Clin Infect Dis. 2001;32:1249-1272.
71. Pettigrew RA, Lang SD, Haydock DA, et al. Catheter-related sepsis in patients on intravenous nutrition: A prospective study of quantitative catheter cultures and guidewire changes for suspected sepsis. Br J Surg. 1985;72:52-55.
72. Raad I, Davis S, Khan A, et al. Impact of central venous catheter removal on the recurrence of catheter-related coagulase-negative staphylococcal bacteremia. Infect Control Hosp Epidemiol. 1992;13:215-221.
73. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30:633-638.
74. Hartstein AI, Mulligan ME, Morthland VH. Recurrent Staphylococcus aureus bacteremia. J Clin Microbiol. 1992;30:670-674.
75. Rosen AB, Fowler VG Jr, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med. 1999;130:810-820.
76. Peacock SJ, Eddleston M, Emptage A, et al. Positive intravenous line tip cultures as predictors of bacteremia. J Hosp Infect. 1998;40:35-38.
77. Arnow PM, Quimosing EM, Beach M. Consequences of intravascular catheter sepsis. Clin Infect Dis. 1993;16:778-784.
78. Hogevik H, Alestig K. Fungal endocarditis: A report on seven cases and a brief review. Infection. 1996;24:17-21.
79. Garrison PK, Freedman LR. Experimental endocarditis I. Staphylococcal endocarditis in rabbits resulting from placement of a polyethylene catheter in the right side of the heart. Yale J Biol Med. 1970;42:394-410.
80. Widmer AF, Nettleman M, Flint K, et al. The clinical impact of culturing central venous catheters. A prospective study. Arch Intern Med. 1992;152:1299-1302.
81. Malanoski GJ, Samore MH, Pefanis A, et al. Staphylococcus aureus catheter-associated bacteremia. Minimal effective therapy and unusual infectious complications associated with arterial sheath catheters. Arch Intern Med. 1995;155:1161-1166.
82. Kentos A, Dufaye P, Jacobs F, et al. Candida albicans septic thrombosis of the right atrium is associated with a central venous catheter. Clin Infect Dis. 1995;21: 440-442.
83. Walsh TJ, Bustamente CI, Vlahov D, et al. Candidal suppurative peripheral thrombophlebitis: Recognition, prevention, and management. Infect Control. 1986;7:16-22.
84. Maki DG, McCormick RD, Uman SJ, et al. Septic endarteritis due to intra-arterial catheters for cancer chemotherapy. I. Evaluation of an outbreak. II. Risk factors, clinical features and management. III. Guidelines for prevention. Cancer. 1979;44:1228-1240.
85. Falk PS, Scuderi PE, Sherertz RJ, et al. Infected radial artery pseudoaneurysms occurring after percutaneous cannulation. Chest. 1992;101:490-495.
86. Benoit D, Decruyenaere J, Vandewoude K, et al. Management of candidal thrombophlebitis of the central veins: Case report and review. Clin Infect Dis. 1998;26: 393-397.
87. Prince A, Heller B, Levy J, et al. Management of fever in patients with central vein catheters. Pediatr Infect Dis. 1986;5: 20-24.
88. Wilson WR, Karchmer AW, Dajani AS, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms American Heart Association. JAMA. 1995;274:1706-1713.